The authors showed that proton radiation therapy increased mesothelin expression, modulated the immunosuppressive microenvironment, and improved the antitumor response of CAR T therapy, underscoring the transformative potential of this strategy.
[Proceedings of The National Academy of Sciences of The United States of America]